The role of automation in drug discovery
Bondy, S.S.
Current Opinion in Drug Discovery and Development 1(1): 116-119
1998
ISSN/ISBN: 1367-6733 PMID: 19649798 Document Number: 490853
Document emailed within 1 workday
Related Documents
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Greenlee, W.J.; Desai, M.C. 2005: The role of medicinal chemists in drug discovery Current Opinion in Drug Discovery and Development 8(4): 419-420
Srivastava, P.; Tiwari, A. 2017: Critical Role of Computer Simulations in Drug Discovery and Development Current Topics in Medicinal Chemistry 17(21): 2422-2432
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
1996: Redesigning drug discovery Nature 384(6604 Suppl): 1-5
Honma, T. 2012: In silico drug discovery and SBDD Nihon Rinsho. Japanese Journal of Clinical Medicine 70 Suppl. 8: 326-330
Cárdenas, M.L.; Cornish-Bowden, A. 2000: Metabolic analysis in drug discovery Science 288(5466): 618-619
Wu, Y-Shan.; Lin, W-Hsing.; Hsu, J.T-A.; Hsieh, H-Pang. 2006: Antiviral drug discovery against SARS-CoV Current Medicinal Chemistry 13(17): 2003-2020
Frigeri, A.; Nicchia, G.Paola.; Svelto, M. 2007: Aquaporins as targets for drug discovery Current Pharmaceutical Design 13(23): 2421-2427
Williams, M. 2004: A return to the fundamentals of drug discovery? Current Opinion in Investigational Drugs 5(1): 29-33
McGowan, J.; Hoth, D. 1989: AIDS drug discovery and development Journal of Acquired Immune Deficiency Syndromes 2(4): 335-343
Bleicher, K.H. 2002: Chemogenomics: bridging a drug discovery gap Current Medicinal Chemistry 9(23): 2077-2084